Disappointing Trial Results for Head and Neck Cancer Treatment
Merck & Co. Inc. and Eisai Co. Ltd. discontinue Phase 3 trial after disappointing results for their Keytruda-Lenvima combination in head and neck canc...
News
Petra Diamonds Reports Higher Revenue in First Diamond Tender of Fiscal 2024
Leading gemstone miner, Petra Diamonds, announces a significant increase in revenue and average price per carat in their first diamond tender of fisca...
FDA Approves First Biosimilar Treatment for Multiple Sclerosis
Biogen shares slip as FDA approves first biosimilar treatment for multiple sclerosis, offering more affordable options for patients. Novartis focuses...
Updated Covid-19 Vaccines Delayed as Hospitalizations Rise
The arrival of this year's updated Covid-19 vaccines at pharmacies will be delayed compared to the previous year, despite the increasing rates of Covi...
Reform Season in China: Boosting Investor Confidence in Securities Markets
China's reform season aims to boost investor confidence in securities markets through proposed measures by the CSRC. Challenges persist in building tr...
Itau Unibanco Sells Banco Itau Argentina to Banco Macro
Itau Unibanco sells Banco Itau Argentina to Banco Macro, impacting its earnings but maintaining a representative office in Argentina.
Fukushima Daiichi Nuclear Plant Begins Release of Treated Radioactive Water into Pacific Ocean
The operator of Fukushima Daiichi nuclear power plant has begun releasing treated radioactive water into the Pacific Ocean. The release, spanning seve...
Embraer Jet Crash Raises Concerns for Russian Private Military Contractor
Investors are not reacting to the safety concerns surrounding the crash of an Embraer jet in Russia, despite the presence of a private military contra...
Supporting Your Son's Artistic Career: A Delicate Balance
Retired parents with a comfortable income must balance support for their artist son while ensuring his financial independence. Evaluating progress and...
Williams-Sonoma Exceeds Q2 Earnings Expectations
Williams-Sonoma reported stronger-than-expected Q2 earnings, raised operating margin guidance, and saw its stock soar by 10%
All Rights Reserved © 2024